Article Listing - Genzyme starts Pompe disease trials

VARIED FORTUNES FOR COLD REMEDIES

9 March 1992

As far as cold remedies in European markets are concerned, 1991 was a year of mixed fortunes. In some, the...

FRENCH GOVT HEALTH COST DEAL

9 March 1992

The government of France appears at last to be prepared to endorse a new agreement on medical fees and drug...

FRENCH PHARMACY MONOPOLY ROW

9 March 1992

A new round of skirmishes has begun on the French drug "frontier" - the controversial legal borderline that separates drugs,...

PFIZER IN JAPANESE ACQUISITION

9 March 1992

US pharmaceutical concern Pfizer has acquired all outstanding shares of Koshin Medical KK, a medical equipment wholesaler in Japan,...

US GOVT "CONCERN" OVER JAPANESE REG MOVES

9 March 1992

The US Department of Commerce in late February officially notified Japan's Ministry of Health and Welfare of its concerns over...

EC SINGLE MARKET "HYPE" WARNING

9 March 1992

Hans Ruediger Vogel, the director of the German drug industry association, the BPI, has warned against excessive expectations from the...

EC PRICE CONTROLS "DO NOT WORK"

9 March 1992

A draft recommendation is currently being circulated for comment by the Commission of the European Comunity, seeking to amend the...

MAbs MAY PROVIDE MS TREATMENT

9 March 1992

A research project carried out by scientists from Athena Neurosci-ences in collaboration with Stanford University of California, USA, and the...

FISONS' US DIFFICULTIES BRING PROFIT DOWN 17%

9 March 1992

Despite a new openness being embarked upon at Fisons since Patrick Egan took over as chairman following the resignation of...

SB'S GEORGE POSTE

9 March 1992

George Poste, chairman of R&D at SmithKline Beecham Pharmaceuticals, has been elected an executive director of Smith-Kline Beecham plc.

Showing 94711-94720 of 95349 articles

Go to beginningPreviousNextGo to end